Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes

Petya Radoeva, Ioana Coman, Cynthia Salazar, Karen Gentile, Anne Higgins, Frank Middleton, Kevin Antshel, Wanda Fremont, Robert Shprintzen, Bernice E. Morrow, Wendy Kates

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Velocardiofacial (VCFS; 22q11.2 deletion) syndrome is a genetic disorder that results from a hemizygous deletion of the q11.2 region on chromosome 22, and is associated with greatly increased risk for psychiatric disorders, including autism spectrum disorder (ASD) and schizophrenia. There is emerging evidence for the involvement of catechol-O-methyltransferase (COMT) and proline dehydrogenase (oxidase) 1 (PRODH) in the psychiatric phenotype of individuals with VCFS. Here, we tested the hypothesis that PRODH and COMT are associated with ASD in youths with VCFS. We found that individuals with VCFS and the low-activity alleles of both PRODH and COMT (rs4819756A and rs4680A) were more likely to present with ASD as compared with individuals with VCFS and the high-activity alleles of these genes [P<0.05; odds ratio=6.0 (95% confidence interval=1.27-28.26; N=87)]. Our results suggest that PRODH and COMT may interact to contribute to the ASD phenotype in individuals with VCFS.

Original languageEnglish (US)
Pages (from-to)269-272
Number of pages4
JournalPsychiatric Genetics
Volume24
Issue number6
DOIs
StatePublished - Dec 12 2014

Fingerprint

Proline Oxidase
DiGeorge Syndrome
Catechol O-Methyltransferase
Genotype
Psychiatry
Alleles
Phenotype
Chromosomes, Human, Pair 22
Inborn Genetic Diseases
Autism Spectrum Disorder
Schizophrenia
Odds Ratio
Confidence Intervals

Keywords

  • 22q11.2 deletion
  • autism spectrum disorder
  • catechol-O-methyltransferase
  • proline dehydrogenase
  • velocardiofacial syndrome

ASJC Scopus subject areas

  • Genetics(clinical)
  • Psychiatry and Mental health
  • Genetics
  • Biological Psychiatry

Cite this

Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes. / Radoeva, Petya; Coman, Ioana; Salazar, Cynthia; Gentile, Karen; Higgins, Anne; Middleton, Frank; Antshel, Kevin; Fremont, Wanda; Shprintzen, Robert; Morrow, Bernice E.; Kates, Wendy.

In: Psychiatric Genetics, Vol. 24, No. 6, 12.12.2014, p. 269-272.

Research output: Contribution to journalArticle

Radoeva, P, Coman, I, Salazar, C, Gentile, K, Higgins, A, Middleton, F, Antshel, K, Fremont, W, Shprintzen, R, Morrow, BE & Kates, W 2014, 'Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes', Psychiatric Genetics, vol. 24, no. 6, pp. 269-272. https://doi.org/10.1097/YPG.0000000000000062
Radoeva, Petya ; Coman, Ioana ; Salazar, Cynthia ; Gentile, Karen ; Higgins, Anne ; Middleton, Frank ; Antshel, Kevin ; Fremont, Wanda ; Shprintzen, Robert ; Morrow, Bernice E. ; Kates, Wendy. / Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes. In: Psychiatric Genetics. 2014 ; Vol. 24, No. 6. pp. 269-272.
@article{46136b73b3654f8580805ac062fa2c18,
title = "Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes",
abstract = "Velocardiofacial (VCFS; 22q11.2 deletion) syndrome is a genetic disorder that results from a hemizygous deletion of the q11.2 region on chromosome 22, and is associated with greatly increased risk for psychiatric disorders, including autism spectrum disorder (ASD) and schizophrenia. There is emerging evidence for the involvement of catechol-O-methyltransferase (COMT) and proline dehydrogenase (oxidase) 1 (PRODH) in the psychiatric phenotype of individuals with VCFS. Here, we tested the hypothesis that PRODH and COMT are associated with ASD in youths with VCFS. We found that individuals with VCFS and the low-activity alleles of both PRODH and COMT (rs4819756A and rs4680A) were more likely to present with ASD as compared with individuals with VCFS and the high-activity alleles of these genes [P<0.05; odds ratio=6.0 (95{\%} confidence interval=1.27-28.26; N=87)]. Our results suggest that PRODH and COMT may interact to contribute to the ASD phenotype in individuals with VCFS.",
keywords = "22q11.2 deletion, autism spectrum disorder, catechol-O-methyltransferase, proline dehydrogenase, velocardiofacial syndrome",
author = "Petya Radoeva and Ioana Coman and Cynthia Salazar and Karen Gentile and Anne Higgins and Frank Middleton and Kevin Antshel and Wanda Fremont and Robert Shprintzen and Morrow, {Bernice E.} and Wendy Kates",
year = "2014",
month = "12",
day = "12",
doi = "10.1097/YPG.0000000000000062",
language = "English (US)",
volume = "24",
pages = "269--272",
journal = "Psychiatric Genetics",
issn = "0955-8829",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes

AU - Radoeva, Petya

AU - Coman, Ioana

AU - Salazar, Cynthia

AU - Gentile, Karen

AU - Higgins, Anne

AU - Middleton, Frank

AU - Antshel, Kevin

AU - Fremont, Wanda

AU - Shprintzen, Robert

AU - Morrow, Bernice E.

AU - Kates, Wendy

PY - 2014/12/12

Y1 - 2014/12/12

N2 - Velocardiofacial (VCFS; 22q11.2 deletion) syndrome is a genetic disorder that results from a hemizygous deletion of the q11.2 region on chromosome 22, and is associated with greatly increased risk for psychiatric disorders, including autism spectrum disorder (ASD) and schizophrenia. There is emerging evidence for the involvement of catechol-O-methyltransferase (COMT) and proline dehydrogenase (oxidase) 1 (PRODH) in the psychiatric phenotype of individuals with VCFS. Here, we tested the hypothesis that PRODH and COMT are associated with ASD in youths with VCFS. We found that individuals with VCFS and the low-activity alleles of both PRODH and COMT (rs4819756A and rs4680A) were more likely to present with ASD as compared with individuals with VCFS and the high-activity alleles of these genes [P<0.05; odds ratio=6.0 (95% confidence interval=1.27-28.26; N=87)]. Our results suggest that PRODH and COMT may interact to contribute to the ASD phenotype in individuals with VCFS.

AB - Velocardiofacial (VCFS; 22q11.2 deletion) syndrome is a genetic disorder that results from a hemizygous deletion of the q11.2 region on chromosome 22, and is associated with greatly increased risk for psychiatric disorders, including autism spectrum disorder (ASD) and schizophrenia. There is emerging evidence for the involvement of catechol-O-methyltransferase (COMT) and proline dehydrogenase (oxidase) 1 (PRODH) in the psychiatric phenotype of individuals with VCFS. Here, we tested the hypothesis that PRODH and COMT are associated with ASD in youths with VCFS. We found that individuals with VCFS and the low-activity alleles of both PRODH and COMT (rs4819756A and rs4680A) were more likely to present with ASD as compared with individuals with VCFS and the high-activity alleles of these genes [P<0.05; odds ratio=6.0 (95% confidence interval=1.27-28.26; N=87)]. Our results suggest that PRODH and COMT may interact to contribute to the ASD phenotype in individuals with VCFS.

KW - 22q11.2 deletion

KW - autism spectrum disorder

KW - catechol-O-methyltransferase

KW - proline dehydrogenase

KW - velocardiofacial syndrome

UR - http://www.scopus.com/inward/record.url?scp=84930088963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930088963&partnerID=8YFLogxK

U2 - 10.1097/YPG.0000000000000062

DO - 10.1097/YPG.0000000000000062

M3 - Article

C2 - 25325218

AN - SCOPUS:84930088963

VL - 24

SP - 269

EP - 272

JO - Psychiatric Genetics

JF - Psychiatric Genetics

SN - 0955-8829

IS - 6

ER -